News


  • Three great reasons to say hi at Hi Europe

    26 November 2018

    FrieslandCampina DOMO will be participating at Health Ingredients Europe 2018 in Frankfurt (Booth 8C51), 27 – 29 November. Three great reasons to say hi:

    • Aequival 2′-FL: The first Human Milk Oligosaccharide (HMO) for next generation infant formulas.
    • Hyvital whey EtD 100 Organic: Extend your organic portfolio with our new organic hydrolysate.
    • Deminal 90 Liquid: Improve sustainability and proteins quality whilst lowering conversion costs.

     

    Read more
  • FrieslandCampina’s new Human Milk Oligosaccharide ingredient, 2’-FL, obtains EU approval and GRAS status

    9 May 2018

    PRESS RELEASE FrieslandCampina DOMO’s new Human Milk Oligosaccharide (HMO) ingredient, 2’-fucosyllactose (2’-FL), has been officially certified to be used in infant formula in both European and U.S. markets. The ingredient has received EU novel food approval and achieved GRAS (Generally Recognised as Safe) status from the Food and Drug Administration (FDA) in the U.S. These authorisations are an important step forward in the plan of FrieslandCampina to launch its first human milk oligosaccharide by the end of the year.

    Read more
  • FrieslandCampina and Glycosyn partner for new infant nutrition ingredients

    11 February 2016

    FrieslandCampina Domo and US-based Glycosyn are combining their expertise into a global partnership to develop new infant nutrition ingredients. The parties signed a technology and partnership agreement. Glycosyn has developed a patented technology for the production of oligosaccharides from lactose. FrieslandCampina Domo will produce and introduce these new ingredients onto the global market.

    Read more